NASDAQ · Biotechnology

CLNN (CLNN) Stock

$4.24 -0.93% NASDAQ: CLNN Healthcare

Valuation

MetricValue
Price$4.24
Market Cap$54.18M
P/E Ratio-1.31
P/B Ratio-2.32
P/S Ratio301.62
EPS (TTM)$0.00
52-Week High$13.50
52-Week Low$3.88
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE214.97%
ROA-171.51%
ROCE-111.61%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-250.10%
Debt/Equity-0.90
Current Ratio0.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$1.0M$0$0
Operating Profit$-50.0M$-48.0M$-41.0M$-33.0M$-23.0M
Net Profit$-10.0M$-30.0M$-50.0M$-39.0M$-26.0M
EPS$-3.16$-4.69$-9.43$-5.67$-2.65
Op Margin-6912.6%-10234.5%-6198.8%-9676.3%-11541.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$63.0M$44.0M$52.0M$27.0M$18.0M
Total Liabilities$50.0M$41.0M$39.0M$36.0M$36.0M
Cash$50.0M$18.0M$29.0M$12.0M$5.0M
Borrowings$24.0M$32.0M$32.0M$21.0M$22.0M

Latest News

Top Premarket Decliners MT Newswires · Jun 22, 2026 Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? Zacks · Jun 18, 2026 Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Zacks · Jun 4, 2026 3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced Simply Wall St. · May 22, 2026 Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year? Zacks · May 19, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-39.0M$-30.0M$-21.0M$-19.0M
Investing Cash Flow$-3.0M$-15.0M$-2.0M$6.0M$0
Financing Cash Flow$-2.0M$0$0$0$0
Net Cash Flow$-9.0M$-32.0M$10.0M$-17.0M$-7.0M
Free Cash Flow$-36.0M$-44.0M$-31.0M$-21.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.64
EV / EBITDA-2.59
FCF Yield-26.87%
Quick Ratio3.07
Interest Coverage-7.05
Return 1Y66.22%
Return 3Y-61.56%
Return 5Y-96.54%

Ownership

Insiders Held17.06%
Institutions Held20.44%
Institutions Float Held24.64%
Institutional HolderSharesReport Date
Boxer Capital Management, LLC477,5152026-03-31
SymBiosis Capital Partners, LLC431,0942026-03-31
Vanguard Capital Management LLC308,2302026-03-31
Scoggin Management, LP300,0002026-03-31
Ensign Peak Advisors, Inc257,8722026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CNTB $2.35 +6.82% -2.31 $147.97M 0.00%
CNTX $0.36 -7.44% -6.84 $33.14M 0.00%
COYA $4.52 -0.88% -2.62 $106.03M 0.00%
MGNX $4.01 +0.38% -2.92 $254.57M 0.00%
ORMP $4.85 -3.49% 2.85 $198.29M 5.84%

About CLNN

CLNN is led by CEO Robert Etherington, employs 75 people, headquartered in US, publicly traded since 2018.

CLNN stock trades at $4.24 with a market capitalization of $54.18M. The stock is valued at a price-to-earnings (P/E) ratio of -1.31, price-to-book of -2.32, price-to-sales of 301.62. Over the past 52 weeks the stock has ranged between $3.88 and $13.50, and currently trades 68.6% below its 52-week high.

On profitability, CLNN generates a return on equity (ROE) of 214.97% — well above the market average, a sign of a high-quality business, return on capital employed of -111.61%, an operating margin of 0.00%, a net profit margin of -250.10%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides